Nitric oxide bioavailability and its potential relevance to the variation in susceptibility to the renal and vascular complications in patients with type 2 diabetes

  1. Kenneth A Earle, MD (k.earle{at}sgul.ac.uk)a,
  2. Diane Harry, RGNa,
  3. Mitra Madhavi, MBBSa,
  4. Karima Zitouni, PhDa and
  5. Jeffrey Barron, PhDb
  1. aRoyal Free and University College Medical School, Whittington Hospital, London UK
  2. bSt Helier Hospital, Carshalton, Surrey, UK

    Abstract

    Objective: We compared the renal and systemic vascular (renovascular) response to reducing bioavailable nitric oxide in patients with type 2 diabetes without nephropathy of African and Caucasian heritage.

    Method: Under euglycaemic conditions, renal blood flow was measured by a constant infusion of paraminohippurate and changes in blood pressure and renal vascular resistance estimated before and after an infusion of L-Ng-monomethyl-l-arginine (L-NMMA).

    Results: In the African heritage group there was a significant fall in renal blood flow (Δ − 46.0 mls/min/1.73 m2;p<0.05) and rise in systolic blood pressure (Δ10.0 [2.3 – 17.9] mmHg; p=0.017) which correlated with an increase in renal vascular resistance (r2=0.77; p=0.004).

    Conclusions: The renal vasconstrictive response associated with nitric oxide synthase inhibition in this study may be of relevance to the observed vulnerability to renal injury in patients of African heritage.

    Footnotes

      • Received May 13, 2008.
      • Accepted October 13, 2008.